Our mission is to manufacture reliable and safe products with the highest quality to help optimize body performance through continuous innovation, education, superior customer service, and teamwork.

Established in 2010, Stability Biologics quickly grew from a medical implant distributor to an  innovative, regenerative medicine company, providing a full line of advanced biologic products to enhance the lives of patients and create greater surgeon satisfaction. In 2014, Stability opened a 21,000 square foot, state of the art product development and processing facility (click here to learn more). This expansion paved the way for Stability to utilize its innovative allograft technology to provide unique and differentiated advanced allograft products for distribution in the surgical fields of spine, orthopedics and wound care.

Reprise Biomedical, Inc. is focused on the development and commercialization of biologic medical devices utilizing a proprietary perfusion decellularization process that delivers superior clinical outcomes in a wide variety of surgical procedures. Reprise commenced operations in 2019 as a spin-out from Miromatrix Medical under proprietary technology licensed from the University of Minnesota.

Shoreline Medical Administration is a specialized medical support company focused on protecting Medicare reimbursements in the skin substitute space. We work closely with biologic manufacturers, distributors, physician practices, and billing teams to optimize clinical documentation and Medicare submissions. Backed by a seasoned executive team, Shoreline leads the industry with cutting-edge AI validation tools that ensure compliance and accuracy in an ever-changing regulatory landscape. Our Clawback Protection Guarantee reflects a firm commitment to innovation, accountability, and peace of mind for our partners.